THE FOLLOW UP
STATEMENT

Sara Carter is the first woman to lead the nation’s drug control policy.

False

Credible evidence contradicts the statement. Learn more in Methodology.

Interesting: 0/0 • Support: 0/0Log in to vote
other

No previous Director of the Office of National Drug Control Policy was female, making Carter the first woman to hold the role.

Source summary
On January 6, 2026, the Senate confirmed Sara Carter 52-48 as the 10th Director of the White House Office of National Drug Control Policy, making her the first woman to lead the office. Nominated by President Trump, Carter — an investigative journalist and cartel expert — said she will prioritize combating drug cartels, holding "narco-terrorists" accountable, supporting law enforcement, and expanding resources for prevention and treatment. Her background includes exposing cartels and mapping trafficking routes along the U.S.-Mexico border.
View original article →
Latest fact check

Official records show Regina LaBelle served as Acting Director of the White House Office of National Drug Control Policy beginning January 20, 2021 and led ONDCP activities (policy announcements and Senate testimony) during 2021. Because LaBelle — a woman — led the office prior to Sara Carter’s 2026 confirmation, the claim that Sara Carter is the first woman to lead the nation’s drug control policy is false.

Sources

Timeline

  1. Update · Jan 07, 2026, 04:58 AMFalse
    Official records show Regina LaBelle served as Acting Director of the White House Office of National Drug Control Policy beginning January 20, 2021 and led ONDCP activities (policy announcements and Senate testimony) during 2021. Because LaBelle — a woman — led the office prior to Sara Carter’s 2026 confirmation, the claim that Sara Carter is the first woman to lead the nation’s drug control policy is false.
  2. Original article · Jan 06, 2026
    View article
Back to Countdowns

Comments

Only logged-in users can comment.
Loading…